Evidence for the involvement of the noradrenergic system, dopaminergic and imidazoline receptors in the antidepressant-like effect of tramadol in mice

Pharmacology Biochemistry and Behavior

Volumn 95, Issue 3, 2010, Pages 344-350

  Jesse, Cristiano R ^a   Wilhelm, Ethel A ^a   Bortolatto, Cristiani F ^a   Nogueira, Cristina W ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Antidepressant; Dopaminergic receptors; Imidazoline; Noradrenergic system; Tramadol

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ALPHA ADRENERGIC RECEPTOR; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; ANTAZOLINE; CAFFEINE; DOPAMINE RECEPTOR; EFAROXAN; HALOPERIDOL; IDAZOXAN; IMIDAZOLINE RECEPTOR; METIROSINE METHYL ESTER; PRAZOSIN; SULPIRIDE; TRAMADOL; YOHIMBINE; ADRENERGIC RECEPTOR; ANTIDEPRESSANT AGENT; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; DEPRESSION; DOPAMINERGIC SYSTEM; DRUG ACTIVITY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME ASSAY; FORCED SWIMMING TEST; HIPPOCAMPUS; MALE; MOUSE; NONHUMAN; NORADRENERGIC SYSTEM; OPEN FIELD TEST; PRIORITY JOURNAL; REARING; ANIMAL; COMPARATIVE STUDY; DOSE RESPONSE; PHYSIOLOGY; PSYCHOLOGY;

ANIMALS; ANTIDEPRESSIVE AGENTS; DEPRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; IMIDAZOLINE RECEPTORS; MALE; MICE; NOREPINEPHRINE; RECEPTORS, ADRENERGIC; RECEPTORS, DOPAMINE; TRAMADOL;

MUS;

EID: 77950461375     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2010.02.011     Document Type: Article

References (59)

1. 1B receptors on the antinociceptive and antidepressant effect of tramadol in mice. Psychopharmacology 2006, 188:111-118.
2. Bousquet P., Bruban V., Schann S., Feldman J. Imidazoline receptors: a challenge. Pharm Acta Helv 2000, 74:205-209.
3. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
4. Brocardo P.S., Budni J., Kaster M.P., Santos A.R., Rodrigues A.L. Folic acid administration produces an antidepressant-like effect in mice: evidence for the involvement of the serotonergic and noradrenergic systems. Neuropharmacology 2008, 54:464-473.
5. Brunello N., Blier P., Judd L.L., Mendlewicz J., Nelson C.J., Souery D., et al. Noradrenaline in mood and anxiety disorders: basic and clinical studies. Int Clin Psychopharmacol 2003, 18:191-202.
6. De Boer T. The pharmacologic profile of mirtazapine. J Clin Psychiatry 1996, 57:19-25.
7. 1A mediated serotonergic neurotranmission. CNS Drugs 1995, 4:18-28.
8. Deniker P. The search for new antidepressant and related drugs. Monoamine oxidase and diseases, prospects for therapy with reversible inhibitors 1984, 3-8. Academic press, New York, NY. K.F. Tipton, D. Dostert, M.S. Benedetti (Eds.).
9. 2A receptor knockout mice. Br J Pharmacol 2001, 134:68-77.
10. Elhwuegi A.S. Central monoamines and their role in major depression. Prog Neuropsychopharmacol Biol Psychiatry 2004, 28:435-451.
11. Faron-Gorecka A., Kusmider M., Inan S.Y., Siwanowicz J., Dziedzicka-Wasylewska M. Effects of tramadol on alpha2-adrenergic receptors in the rat brain. Brain Res 2004, 1016:263-267.
12. Garcia-Sevilla J.A., Escriba P.V., Sastre M., Walzer C., Busquets X., Jaquet G. Immunodetection and quantitation of imidazoline receptor proteins in platelets of patients with major depression and in brains of suicide victims. Arch Gen Psychiatry 1996, 53:803-810.
13. Halaris A., Zhu H., Ali J., Nasrallah A., De Vane C.L., Piletz J.E. Downregulation of platelet imidazoline-1-binding sites after bupropion treatment. Int J Neuropsychopharmacol 2002, 5:37-46.
14. Hennies H.H., Friderichs E., Schneider J. Receptor binding, analgesic and antitussive potency of tramadol and other selected opioids. Arzneimittelforschung 1988, 38:877-880.
15. Holt A. Imidazoline binding sites on receptors and enzymes: emerging targets for novel antidepressant drugs?. J Psychiatry and Neurosci 2003, 28:409-414.
16. Hopwood S.E., Owesson C.A., Callado L.F., McLaughlin D.P., Stamford J.A. Effects of chronic tramadol on pre- and post-synaptic measures of monoamine function. J Psychopharmacol 2001, 15:147-153.
17. Jesse C.R., Bortolatto C.F., Savegnago L., Rocha J.B., Nogueira C.W. Involvement of l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of tramadol in the rat forced swimming test. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:1838-1843.
18. Jesse C.R., Wilhelm E.A., Barbosa N.B., Nogueira C.W. Involvement of different types of potassium channels in the antidepressant-like effect of tramadol in the mouse forced swimming test. Eur J Pharmacol 2009, 613:74-78.
19. Kapur S., Mann J.J. Role of the dopaminergic system in depression. Biol Psychiatry 1992, 32:1-17.
20. 1A receptors in the antidepressant-like effect of adenosine in the mouse forced swimming test. Brain Res Bull 2004, 67:53-61.
21. Kaster M.P., Rosa A.O., Santos A.R., Rodrigues A.L. Involvement of nitric-oxide-cGMP pathway in the antidepressant-like effect of adenosine in the forced swimming test. Int J Neuropsychopharmacol 2005, 8:601-606.
22. Kaster M.P., Raupp I., Binfare R.W., Andreatini R., Rodrigues A.L. Antidepressant-like effect of lamotrigine in the mouse forced swimming test: evidence for the involvement of the noradrenergic system. Eur J Pharmacol 2007, 565:119-124.
23. Kelder J., Funke C., De Boer T., Delbressine L., Leysen D., Nicholson V. A comparison of the physicochemical and biological properties of mirtazapine and mianserin. J Pharm Pharmacol 1997, 49:403-411.
24. Krajl M. A rapid microfluorimetric determination of monoamine oxidase. Biochem Pharmacol 1965, 14:1684-1686.
25. 3 receptor gene expression as a common effect of chronic antidepressant treatments. Mol Psychiatry 2000, 5:378-388.
26. Lanni C., Govoni S., Lucchelli A., Cinzia B. Depression and antidepressants: molecular and cellular aspect. Cell Mol Life Sci 2009, 66:2985-3008.
27. 2A receptors in the antidepressant-like effect of zinc in the forced swimming test. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:994-999.
28. Machado D.G., Kaster M.P., Binfare R.W., Dias M., Santos A.R., Pizzolatti M.G., et al. Antidepressant-like effect of the extract from leaves of Schinus molle L. in mice: evidence for the involvement of the monoaminergic system. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31:421-428.
29. 2 receptors in the rat brain. Eur J Pharmacol 1996, 304:49-54.
30. Matsumoto T., Furuta T., Nimura Y., Suzuki O. 3-(p-hydroxyphenyl)propionic acid as a new fluorogenic reagent for amine oxidase assays. Anal Biochem 1984, 138:133-136.
31. Mayorga A.J., Dalvi A., Page M.E., Zimov-Levinson S., Hen R., Lucki I. Antidepressant-like behavioral effects in 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) receptor mutant mice. J Pharmacol Exp Ther 2001, 298:1101-1107.
32. Millan M.J. The role of monoamines in the actions of established and "novel" antidepressant agents: a critical review. Eur J Pharmacol 2004, 500:371-384.
33. Neumeister A., Willeit M., Praschak-Rieder N., Asenbaum S., Stastny J., Hilger E., et al. Dopamine transporter availability in symptomatic depressed patients with seasonal affective disorder and healthy controls. Psychol Med 2001, 31:1467-1473.
34. O'Leary O.F., Bechtholt A.J., Bechtholt A.J., Crowley J.J., Hill T.E., Page M.E., et al. Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test. Psychopharmacology 2007, 192:357-371.
35. Palucha A., Pilc A. On the role of metabotropic glutamate receptors in the mechanisms of action of antidepressants. Pol J Pharmacol 2002, 54:581-586.
36. Papakostas G.I. Dopaminergic-based pharmacotherapies for depression. Eur Neuropsychopharmacol 2006, 16:391-402.
37. Piletz J.E., Baker R., Halaris A. Platelet imidazoline receptors as state marker of depressive symptomatology. J Psychiatr Res 2008, 42:41-49.
38. Porsolt R.D., Le Pichon M., Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 1977, 266:730-732.
39. Prange A. Proceedings: behavioral effects of hypothalamic polypeptides in animals and man. Psychopharmacol Bull 1974, 10:11-15.
40. Raffa R.B., Friderichs E., Reimann W., Shank R.P., Codd E.E., Vaught J.L. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic. J Pharmacol Exp Ther 1992, 260:275-285.
41. Reddy P.L., Khanna S., Subhash M.N., Channabasavanna S.M., Rao B.S. CSF amine metabolites in depression. Biol Psychiatry 1992, 31:112-118.
42. Regunathan S., Reis D.J. Imidazoline receptors and their endogenous ligands. Annu Rev Pharmacol Toxicol 1996, 36:511-544.
43. 3 receptors in the rat brain differentiated by agonist and antagonist binding-an autoradiographic analysis. Naunyn Schmiedebergs Arch Pharmacol 1999, 359:178-186.
44. Rojas-Corrales M.O., Gibert-Rahola J., Mico J.A. Tramadol induces antidepressant-type effects in mice. Life Sci 1998, 63:PL175-PL180.
45. Rojas-Corrales M.O., Berrocoso E., Gibert-Rahola J., Mico J.A. Antidepressant-like effects of tramadol and other central analgesics with activity on monoamines reuptake, in helpless rats. Life Sci 2002, 72:143-152.
46. Rojas-Corrales M.O., Berrocoso E., Gibert-Rahola J., Mico J.A. Antidepressant-like effect of tramadol and its enantiomers in reserpinized mice: comparative study with desipramine, fluvoxamine, venlafaxine and opiates. J Psychopharmacol 2004, 18:404-411.
47. Shah B.H., Saeed S.A., Rashid F., Gilani A.H. Dopamine potentiation of calcium ionophore, A-23187-induced platelet aggregation. Adv Exp Med Biol 1997, 407:537-540.
48. Shapira N.A., McConville B.J., Pagnucco M.L., Norman A.B., Keck P.E. Novel use of tramadol hydrochloride in the treatment of Tourette's syndrome. J Clin Psychiatry 1997, 58:174-175.
49. Shapira N.A., Verduin M.L., DeGraw J.D. Treatment of refractory major depression with tramadol monotherapy. J Clin Psychiatry 2001, 62:205-206.
50. Smith K.L., Jessop D.S., Finn D.P. Modulation of stress by imidazoline binding sites: implications for psychiatric disorders. Stress 2009, 12:97-114.
51. Soto-Otero R., Mendez-Alvarez E., Hermida-Ameijeiras A., Sanchez-Sellero I., Cruz-Landeira A., Lamas M.L. Inhibition of brain monoamine oxidase activity by the generation of hydroxyl radicals: potential implications in relation to oxidative stress. Life Sci 2001, 69:879-889.
52. Spencer C. The efficacy of intramuscular tramadol as a rapid-onset antidepressant. Aust N Z J Psychiatry 2000, 34:1032-1033.
53. Walsh R.N., Cummins R.A. The open-field test: a critical review. Psychol Bull 1976, 83:482-504.
54. Widerlov E., Lewander T. Tolerance to alpha-methyl-p-tyrosine in rats: studies on the antagonism of amphetamine-induced motor activity and excitatory behaviour. Psychopharmacology (Berl) 1978, 60:41-45.
55. Yalcin I., Aksur F., Belzung C. Effects of desipramine and tramadol in a chronic mild stress model in mice are altered by yohimbine but not by pindolol. Eur J Pharmacol 2005, 514:165-174.
56. Yalcin I., Coubard S., Bodard S., Chalon S., Belzung C. Effects of 5, 7-dihydroxytryptamine lesion of the dorsal raphe nucleus on the antidepressant-like action of tramadol in the unpredictable chronic mild stress in mice. Psychopharmacology 2008, 200:497-507.
57. Zeidan M.P., Zomkowski A.D., Rosa A.O., Rodrigues A.L., Gabilan N.H. Evidence for imidazoline receptors involvement in the agmatine antidepressant-like effect in the forced swimming test. Eur J Pharmacol 2007, 565:125-131.
58. Zhu H., Halaris A., Madakasira S., Pazzaglia P., Goldman N., De Vane C.L. Effect of bupropion on immunodensity of putative imidazoline receptors on platelets of depressed patients. J Psychiatr Res 1999, 33:323-333.
59. Zomkowski A.D., Santos A.R., Rodrigues A.L. Putrescine produces antidepressant-like effects in the forced swimming test and in the tail suspension test in mice. Prog Neuropsychopharmacol Biol Psychiatry 2006, 30:1419-1425.